Beat The FTSE 100 With SABMiller plc, GlaxoSmithKline plc And British American Tobacco plc!

SABMiller plc (LON: SAB), GlaxoSmithKline plc (LON: GSK) and British American Tobacco plc (LON: BATS) could help you to outperform the FTSE 100

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE100

With the FTSE 100 having fallen by over 8% during the last month, beating the returns on the index has become a priority for a number of UK investors.

Of course, doing so is easier said than done. However, with the FTSE 100 seemingly in freefall at present, one way of achieving this aim is to buy relatively stable companies that are likely to continue to deliver strong earnings growth – even if the Eurozone moves back into recession.

With that in mind, here are three companies that offer just that and, as a result, could beat the FTSE 100 over the medium to long term.

SABMiller

When it comes to past earnings growth, SABMiller’s (LSE: SAB) track record is superb. Indeed, it has increased the bottom line in every one of the last five years, with annual growth averaging 12%.

Furthermore, SABMiller is expected to increase earnings by 5% in the current year and by another 10% next year. The main attraction, though, is the certainty with which such growth prospects can be viewed, since SABMiller’s products sell whether the world economy is performing well or not.

As a result, its current valuation premium relative to the FTSE 100 could be expanded further. So, while a price to earnings (P/E) ratio of 20.3 may seem high, it has been much higher in the past and could return there if there is a ‘flight to safety’ by investors moving forward.

GlaxoSmithKline

Even if the Eurozone slips back into recession, GlaxoSmithKline’s (LSE: GSK) (NYSE: GSK.US) fortunes are more closely linked to its pipeline than to the macroeconomic outlook. On this front GlaxoSmithKline has huge potential and, since selling off its consumer businesses, is even more focused on developing key, blockbuster drugs that can generate increased sales and profits for the company.

With a yield of 6.1%, shares in GlaxoSmithKline offer highly attractive income prospects. Furthermore, on a P/E ratio of 14.2, they look great value compared to sector peers, too.

British American Tobacco

While tobacco stocks generally deliver stable growth, British American Tobacco (LSE: BATS) (NYSE: BTI.US) has the potential to grow its bottom line at a rapid rate. That’s because it arrived early on the e-cigarette scene and, as a result, has stolen a march on many of its key rivals.

Indeed, the e-cigarette market has bright prospects. It is estimated that they are far less harmful than cigarettes and, as a result, are being allowed to advertise much more freely than tobacco products would be. This could, of course, attract people back to smoking who have quit, or simply increase the number of overall smokers, since the health risks are arguably not as great.

Either way, it’s good news for British American Tobacco. Furthermore, with a yield of 4.3%, it could prove to be a strong income and growth play moving forward.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens owns shares of GlaxoSmithKline and British American Tobacco. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »